Open AccessRe: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID ‐19?
Author(s) -
Liu Xiao,
Long Chuyan,
Xiong Qinmei,
Chen Chen,
Ma Jianyong,
Su Yuhao,
Hong Kui
Publication year - 2021
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23473
Subject(s) - medicine , angiotensin converting enzyme , angiotensin converting enzyme 2 , pharmacology , covid-19 , angiotensin receptor , ace inhibitor , enzyme inhibitor , peptidyl dipeptidase a , renin–angiotensin system , receptor , enzyme , angiotensin receptor blockers , angiotensin ii receptor type 1 , angiotensin ii , virology , biochemistry , disease , blood pressure , chemistry , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom